The Lord Vallance of Balham KCB
Labour
Member of the House of Lords
M
Lord Vallance of Balham's full title is The Lord Vallance of Balham KCB. His name is Patrick John Thompson Vallance, and he is a current member of the House of Lords.
Allowance claims · 2026
Daily attendance allowance
£0
14 days attended across 1 published month
Total claimed
£0
Source: House of Lords Finance Office monthly publications, refreshed on the 5th of each month.
Ministerial activity
Records on file
570
564 meetings ·
0 hospitality ·
0 gifts ·
6 overseas trips
· 2024-07-01 → 2026-03-31
Total overseas travel cost
£14,463
Recent meetings · latest 20 of 564
| Date | Met with | Purpose | Source |
|---|---|---|---|
| 2026-03-27 | Vertex Pharmaceuticals | To discuss investment opportunities | department-for-science-innovation-and-technology |
| 2026-03-26 | Quantinuum | To discuss opportunities for the UK Quantum ecosystem. | department-for-science-innovation-and-technology |
| 2026-03-26 | Medical Research Council | To discuss research environment | department-for-science-innovation-and-technology |
| 2026-03-26 | OpenSAFELY | To discuss ongoing work in data projects | department-for-science-innovation-and-technology |
| 2026-03-24 | Rigetti Computing | To discuss opportunities for the UK Quantum ecosystem. | department-for-science-innovation-and-technology |
| 2026-03-23 | Infleqtion | To discuss opportunities for the UK Quantum ecosystem. | department-for-science-innovation-and-technology |
| 2026-03-23 | Eli Lilly | To discuss UK commercial environment | department-for-science-innovation-and-technology |
| 2026-03-23 | Imperial / SynBiCite, GCSA, Sixfold, Nanosyrinx, Potter Clarkson, BBSRC, EPSRC, Innovate UK, Extracellular, Imperial College London,C3 Biotech, Innovate UK, Director for Engineering Biology, Professor John Innes Centre, Biome Technologies, Manchester University, Astra Zeneca | Quarterly roundtable to discuss how HMG can support engineering biology companies to scale in the UK, how to support Supply chains, and where best to engage with other governments in international work. | department-for-science-innovation-and-technology |
| 2026-03-23 | Royal Society | To discuss ongoing work at the Royal Society as part of regular engagement with national academies | department-for-science-innovation-and-technology |
| 2026-03-20 | Silverstone Circuits Limited | Attended the Silverstone Vision Board, discussing alignment with the UK's OxCam strategy | department-for-science-innovation-and-technology |
| 2026-03-19 | Nuffield Department of Primary Care Health Sciences | NDPCHS Inaugural Annual Lecture | department-for-science-innovation-and-technology |
| 2026-03-19 | HDRS | To discuss progress in establishing HDRS | department-for-science-innovation-and-technology |
| 2026-03-18 | Flagship Pioneering | To discuss current and potential future areas of collaboration | department-for-science-innovation-and-technology |
| 2026-03-18 | Business Board Network | To meet regional business leaders and discuss innovative practises across the UK | department-for-science-innovation-and-technology |
| 2026-03-12 | Paul Hudson | To discuss potential areas for future collaboration. | department-for-science-innovation-and-technology |
| 2026-03-12 | Animals in Science Committee, NC3Rs, Understanding Animals In Research | To discuss the delivery of the Replacing Animals in Science Strategy | department-for-science-innovation-and-technology |
| 2026-03-12 | ARIA, Oxa, Reach Robotics, Airbus, Cranfield University, techUK, CMR Surgical,University of Oxford, UKAEA, Starship Technologies, National Robotarium, Birmingham University, Tharsus, ACUA Ocean, Automate UK, ManufactuTechnology Centre | First meeting of the Robotics Advisory Group to discuss the UK's robotics strategy and receive input from experts for the shaping of policy. | department-for-science-innovation-and-technology |
| 2026-03-10 | Sanofi | To discuss the UK Life Sciences Sector | department-for-science-innovation-and-technology |
| 2026-03-05 | Pharmaceutical companies and trade associations | Oversight Committee to discuss the UK Life Sciences Sector and the UK-US Pharmaceuticals Arrangement | department-for-science-innovation-and-technology |
| 2026-03-02 | Novo Holdings | To discuss areas of collaboration and opportunities for UK growth. | department-for-science-innovation-and-technology |
Recent overseas travel
| Dates | Destination | Purpose | Total cost |
|---|---|---|---|
| 2025-11-10 → 2025-11-12 |
Beijing; China, Guangzhou; China
Scheduled flight
|
To promote UK and China joint research | £6,335 |
| 2025-07-16 → 2025-07-17 |
Copenhagen, Denmark
Scheduled flight
|
Attend the Informal Competitiveness Council hosted by the Danish National Government | £377 |
| 2025-06-15 → 2025-06-18 |
Boston, USA
Scheduled Flight
|
To promote: (1) UK Life Sciences objectives at the BIO Convention; (2) UK Science and Technology interests aligned to a new UK-US Tech Partnership. | £5,832 |
| 2025-01-07 → 2025-01-08 |
Copenhagen, Denmark
Scheduled Flight
|
Artic and Climate Science discussion with scientists including recipients of ARIA funding. Engagements with representatives of the Danish Government. | £383 |
| 2024-12-08 → 2024-12-11 |
Berne and Zurich, Switzerland & Stockhom, Sweden
Scheduled Flight
|
To attend the JCM for the MoU on Switzerland, and to attend the Nobel Prize Ceremony. | £977 |
| 2024-07-09 → 2024-07-10 |
Bologna, Italy
Scheduled Flight
|
G7 | £559 |
Source: gov.uk ministerial transparency returns. Coverage:
HM Treasury and DSIT. Published quarterly under the Ministerial
Code; refreshed monthly on the 7th.
Lords votes · 2026
189 divisions
5 Content(2.6%)
154 Not-Content(81.5%)
30 didn't vote(15.9%)
2026-07-13
Not-Content
158–239
Not-Content
2026-04-27
Not-Content
58–138
Not-Content
2026-04-23
Not-Content
152–207
Not-Content
2026-04-13
Not-Content
65–173
Not-Content
2026-04-13
Not-Content
178–231
Not-Content
2026-04-13
Not-Content
69–332
Not-Content
2026-03-26
Not-Content
115–197
Not-Content
2026-03-26
Not-Content
64–140
Not-Content
2026-03-25
Not-Content
95–137
Not-Content
2026-03-24
Not-Content
80–166
Not-Content
2026-03-05
Not-Content
193–143
Content
2026-03-05
Not-Content
194–140
Content
2026-03-05
Not-Content
198–139
Content
2026-03-05
Not-Content
208–142
Content
2026-03-05
Not-Content
214–142
Content
2026-02-04
Not-Content
62–295
Not-Content
2026-01-12
Not-Content
201–169
Content
2026-01-05
Not-Content
131–127
Content
2026-01-05
Not-Content
194–130
Content
2026-01-05
Not-Content
168–178
Not-Content
2026-01-05
Not-Content
210–131
Content
2026-01-05
Not-Content
132–124
Content
Source: lordsvotes-api.parliament.uk. "Result" shows the headline
Content vs Not-Content tally (including tellers). The Lords doesn't
publish a "didn't vote" attendance roll like the Commons, so the
figure above conflates absence with abstention.
Recent Hansard contributions · latest 25
2026-07-09
Artificial Intelligence: Vaccine Technology
This is precisely why the Health Data Research Service is being set up: to make sure that we have a place where data can be collated properly and accessed in an appropriate way, and that the benefit returns to the NHS and to patients in this country as t
2026-07-09
Artificial Intelligence: Vaccine Technology
Obviously, the intellectual property that is being laid down as part of this process will belong to the university, the funder to some extent, and the company. The exploitation of IP demands that there is clarity on IP ownership in order to get the inwar
2026-07-09
Artificial Intelligence: Vaccine Technology
Public acceptance of vaccination is very high in this country, and that is built on trust, part of which comes from the regulator. The regulator in this country is extremely rigorous and will make sure that all the usual things that a vaccine needs to g
2026-07-09
Artificial Intelligence: Vaccine Technology
This is a very hot topic of discussion. A lot is going on between nations and it is a big topic at the G7, where the UK is leading on some of these discussions.
2026-07-09
Artificial Intelligence: Vaccine Technology
As the noble Lord says, the 100-day mission was endorsed at the 2021 G7, and I was very involved in that process. AI will be a critical part of how we do vaccines, therapeutics and diagnostics, and I am optimistic that this makes the 100-day mission real
2026-07-09
Artificial Intelligence: Vaccine Technology
The MHRA is one of the most important and best regulators in the world for medicines, and none of the requirements for an AI-assisted vaccine design is different from those for a normal one. In other words, it has to be looked at in the same way, with th
2026-07-09
Artificial Intelligence: Vaccine Technology
I thank the noble Lord for his question. The point about the technology is that an enormous amount of good comes from it, and we must not forget that. But yes, there are risks, and we are looking at nucleic acid synthesis using the programmes now availab
2026-07-09
Artificial Intelligence: Vaccine Technology
In the UK there is a programme called Our Future Health, designed to enrol 5 million participants. It is very clearly designed to be an accurate representation of the UK population as a whole, with all our ethnic diversity and across age ranges. That is
2026-07-09
Artificial Intelligence: Vaccine Technology
I completely agree that this technology is hugely important for the good it can do in making vaccines and new medicines. It will change our ability to treat and prevent diseases. It is also true that the same technology can be used for bad things. Like m
2026-07-09
Artificial Intelligence: Vaccine Technology
I thank my noble friend for the question. That is largely a DHSC responsibility. DSIT makes sure that there is a real pipeline of new vaccines coming through, that the environment is right for companies to form and grow in this country and that we are at
2026-07-09
Artificial Intelligence: Vaccine Technology
The results from Cambridge and the DIOSynVax programme, primarily funded by the Government through Innovate UK, is a good example of how the Government are taking AI’s potential in vaccine technology seriously. AI’s most credible contribution to vaccine
I thank the noble Earl, Lord Russell, and the noble Lord, Lord Moynihan, for the support and the useful additional questions. I thank the noble Lord, Lord Moynihan, for his wish to be opposite me for a long time. I cannot make any guarantees on that.
My Lords, these draft regulations were laid before the House on 23 April 2026. I want to briefly outline the purpose of nuclear safeguards and explain the proposed amendments to the nuclear safeguards regulations. These regulations form the foundation of
That the Grand Committee do consider the Nuclear Safeguards (EU Exit and Fees) (Amendment) Regulations 2026.
2026-04-28
UK Biobank Data
Again, let me thank another participant at UK Biobank. One of the features I have found whenever I have met UK Biobank participants or visitors is how incredibly altruistic everybody is: they want to do it for the common good. That is a very common theme
2026-04-28
UK Biobank Data
My Lords, I am grateful to the noble Lords, Lord Markham and Lord Clement-Jones, for those responses and questions. The Government agree that this is unacceptable; it is an abuse of UK Biobank’s data and something that we take extremely seriously, and it
2026-04-28
UK Biobank Data
Yes, we are very aware of the possibility that there are things on GitHub. There has been a GitHub issue related to this, which was identified earlier this year, and that will be part of what UK Biobank looks at. Going forward, that will not be possible
2026-04-28
UK Biobank Data
UK Biobank, for all the reasons stated, is expensive to run, and it is run with a mix of funding from government, charities and industry, with the major funders being the UK Government and the Wellcome Trust over many years. The principle of it has been
2026-04-28
UK Biobank Data
That last point is fundamental: we must have trust. If we do not get trust, we lose the ability to use what is an extraordinary resource, so that has to be part of what is looked at here. It is absolutely part of what the board of UK Biobank is doing in
2026-04-28
UK Biobank Data
UK Biobank referred itself to the ICO, which was the entirely appropriate thing to do. The matter is now in the ICO’s hands.
2026-04-28
UK Biobank Data
I thank my noble friend for the question. UK Biobank has identified the sites that were responsible for the leak. There were three institutions: the Second Xiangya Hospital, China-Japan Union Hospital, and Beijing Chaoyang Hospital. Those institutions ha
2026-04-28
UK Biobank Data
Let me thank the noble Lord, Lord Tarassenko, and his wife for participating in UK Biobank, because the whole thing depends on that. He is quite right that, before 2024, the data was downloaded and people did their research on downloaded data. I have ha
2026-04-28
UK Biobank Data
I can absolutely assure the noble Lord that the Government will issue guidance. That guidance was in development anyway, and I expect it to come out within the next few weeks. I can also assure him that other platforms use secure data platforms where the
2026-04-28
UK Biobank Data
I thank the noble Lord for his questions, and I echo his points about the Front-Bench spokesmen on the other side. It is very clear that everyone has the same intent here, which is to try to sort this out, and I welcome those inputs.
I agree that this
2026-04-28
UK Biobank Data
This is somewhat off topic. In terms of China, I think it is very clear that there are three possibilities for where Covid came from. One is that it was a natural infection that spilled over from bats, with billions of chances for that to happen. The sec
Source: hansard.parliament.uk via hansard-api. Snippets shown
verbatim from the search API; click any debate title for the full record.
Register of Interests · 4 entries on file
Declarations under the Lords Code of Conduct. Free text — no monetary values, no hours worked. A declaration that an interest exists, not a claim about its size.
Category 1: Remunerated employment etc.
-
Minister of State for Science, Innovation, Research and Nuclear, Department for Science, Innovation and Technology, and Department for Energy Security and Net Zero (interest ceased 22 July 2026)
registered 2024-08-01 · amended 2026-09-03
-
Director, SARL Dexter/Vallance (French company for letting the member and his wife's property)
registered 2024-08-01 · amended 2025-04-05
Category 2: Shareholdings etc. (a)
-
SARL Dexter/Vallance (French company for letting the member and his wife's property)
registered 2024-08-01 · amended 2025-04-05
Category 3: Land and property
-
Property in France from which rental income is received via SARL Dexter/Vallance
registered 2024-08-01 · amended 2025-04-05
Source: UK Parliament Members API (Lords register). Refreshed weekly.
Read the full
Lords Code of Conduct
for what each category covers and the disclosure thresholds.
Party history
2024-07-17 → present
Labour
current
Government posts
2025-09-06 → 2026-07-22
Minister of State (Department for Energy Security and Net Zero)
2024-07-05 → 2026-07-22
Minister of State (Department for Science, Innovation and Technology)
Opposition posts
None recorded.
Committee memberships
None recorded.
Contact
Parliamentary office
contactholmember@parliament.uk
020 7219 5353 · House of Lords, London, SW1A 0PW
020 7219 5353 · House of Lords, London, SW1A 0PW
APPGs (2026) · 0 active officership(s)
No APPG officerships found for this peer. (Officer matching is by name —
if the parliamentary register lists them under a slightly different
form, the join may miss; check
/appgs directly.)
Written parliamentary questions · 2026
No written questions tabled in 2026.
Bills sponsored & supported · 2026
0 bills
0 as lead sponsor
0 as supporter
No bills sponsored or supported in 2026.
Source: UK Parliament Bills API. "Lead" sponsor is the
primary mover (sortOrder = 1); "Supporter" rows are
members of either House who
backed the bill at introduction. Year is the bill's first-reading
date.
Historic bills (all-time)
0 bills
0 as lead sponsor
0 as supporter
No bills sponsored or supported on record.
Same source as the year-scoped panel above, but unconstrained by
year. The "Sponsored" tag = lead sponsor; "Supported" = backed at
introduction. Sorted newest first.